Bcel stock forecast.

The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ...Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of 1,479.44% from the latest price.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.

DUK Stock 12 Months Forecast. $97.00. (4.71% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Duke Energy in the last 3 months. The average price target is $97.00 with a high forecast of $103.00 and a low forecast of $89.00. The average price target represents a 4.71% change from the last price of $92.64.

Coterra Energy Inc () Stock Market info Recommendations: Buy or sell Coterra Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below.According to present data Coterra Energy's CTRA shares and potentially its market environment have …The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL.

The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...

Atreca Inc [BCEL] stock is trading at $0.22, up 8.95%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. ... An investor can expect a potential return of 1377.27% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In the same period, the company ...

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ...Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —. Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50. The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...FIXX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Homology Medicines in the last 3 months. The average price target is $1.50 with a high forecast of $1.50 and a low forecast of $1.50. The average price target represents a 167.81% change from the last price of $0.56.Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...A treca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...Find the latest Atreca, Inc. (BCEL) stock quote, history, news and other vital information to help you with your stock trading and investing.VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...Shares in Artego SA last closed at RON15.30 and the price had moved by +23.39% over the past 365 days. In terms of relative price strength the Artego SA share price has outperformed the FTSE Global All Cap Index by +15.74% over the past year.Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL.

NSD:BCEL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Based on the Atreca Inc stock forecast from 3 analysts, the average analyst target price for Atreca Inc is USD 1.00 over the next 12 months.Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.Find the latest W&T Offshore, Inc. (WTI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the July 20, 2020 when the stock price was at 15.10$.. In the short term (2weeks), BCEL's stock price should outperform the market by 2.41%.During that period the price should oscillate between -10.29% and +13.88%.. In the medium term (3months), BCEL's stock …See Atreca, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — …BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...

Atreca Inc Cl A stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction. ... BCEL Related stocks. Symbol 3M %Chg ; BCEL -64.18% : Atreca Inc Cl A: AMGN +16. ...

HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.

Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...Nov 29, 2023 · Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%. For Atreca stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Atreca stock forecast of $0.23, a high forecast of $0.23, and a low forecast of …

Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.$0.22 USD +0.01 (2.90%) Updated Nov 27, 2023 11:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value | A Growth | C Momentum | C VGM Industry …Complete Atreca Inc. Cl A stock information by Barron's. View real-time BCEL stock price and news, along with industry-best analysis.Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCLI stock returns are also predicted based on historical data. According to our research, BCLI stock is a bad long-term investment. BCLI share price has been in a bear cycle for the past year.Instagram:https://instagram. worth of bar of goldbest utility etfsacciones de inteligencia artificialvaneck morningstar wide moat etf Apr 6, 2023 · Zacks Equity Research. April 6, 2023 at 9:55 AM · 3 min read. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was ... nvda price targetshow much is tradestation per month The average Qifu Technology stock price prediction forecasts a potential upside of 57.86% from the current QFIN share price of $15.52. What is QFIN's forecast return on equity (ROE) for 2023-2025? (NASDAQ: QFIN) forecast ROE is N/A, which is considered weak. best health insurance companies virginia Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ... The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...